Agriculture & Biology
Respiratory syncytial virus
96%
vaccine development
79%
vaccines
31%
income
15%
burden of disease
13%
pregnant women
11%
immunology
11%
stakeholders
10%
respiratory tract diseases
9%
endpoints
9%
infectious diseases
9%
hypersensitivity
9%
public health
8%
industry
6%
Medicine & Life Sciences
Respiratory Syncytial Virus Vaccines
100%
Education
40%
Vaccines
24%
Health Services Needs and Demand
23%
Income
17%
National Institute of Allergy and Infectious Diseases (U.S.)
16%
Respiratory Syncytial Viruses
12%
Allergy and Immunology
11%
Congresses
10%
Biological Products
10%
Industry
9%
Evaluation Studies
9%
Child
9%
Public Health
7%
Elderly
7%
Technology
7%
Social Sciences
infant
21%
income
17%
allergy
16%
cause
15%
pregnant women
14%
contagious disease
12%
illness
10%
low income
10%
public health
9%
stakeholder
8%
industry
7%
evaluation
5%